Metabolomics

Dataset Information

0

Non-invasive urinary metabolomic profiles discriminate biliary atresia from infantile hepatitis syndrome


ABSTRACT:

INTRODUCTION: Neonatal cholestatic disorders are a group of hepatobiliary diseases occurring in the first 3 months of life. The most common causes of neonatal cholestasis are infantile hepatitis syndrome (IHS) and biliary atresia (BA). The clinical manifestations of the two diseases are too similar to distinguish them. However, early detection is very important in improving the clinical outcome of BA. Currently, a liver biopsy is the only proven and effective method used to differentially diagnose these two similar diseases in the clinic. However, this method is invasive. Therefore, sensitive and non-invasive biomarkers are needed to effectively differentiate between BA and IHS. We hypothesized that urinary metabolomics can produce unique metabolite profiles for BA and IHS.
OBJECTIVES: The aim of this study was to characterize urinary metabolomic profiles in infants with BA and IHS, and to identify differences among infants with BA, IHS, and normal controls (NC).
METHODS: Urine samples along with patient characteristics were obtained from 25 BA, 38 IHS, and 38 NC infants. A non-targeted gas chromatography-mass spectrometry (GC-MS) metabolomics method was used in conjunction with orthogonal partial least squares discriminant analysis (OPLS-DA) to explore the metabolomic profiles of BA, IHS, and NC infants.
RESULTS: In total, 41 differentially expressed metabolites between BA vs. NC, IHS vs. NC, and BA vs. IHS were identified. N-acetyl-D-mannosamine and alpha-aminoadipic acid were found to be highly accurate at distinguishing between BA and IHS.
CONCLUSIONS: BA and IHS infants have specific urinary metabolomic profiles. The results of our study underscore the clinical potential of metabolomic profiling to uncover metabolic changes that could be used to discriminate BA from IHS.

INSTRUMENT(S): Gas Chromatography MS - Positive (GC-MS (Positive))

SUBMITTER: weiwei li 

PROVIDER: MTBLS689 | MetaboLights | 2019-06-25

REPOSITORIES: MetaboLights

Dataset's files

Source:
Action DRS
MTBLS689 Other
FILES Other
a_MTBLS689_metabolite_profiling_mass_spectrometry.txt Txt
i_Investigation.txt Txt
m_MTBLS689_metabolite_profiling_mass_spectrometry_v2_maf.tsv Tabular
Items per page:
1 - 5 of 7
altmetric image

Publications

Non-invasive urinary metabolomic profiles discriminate biliary atresia from infantile hepatitis syndrome.

Li Wei-Wei WW   Yang Yan Y   Dai Qi-Gang QG   Lin Li-Li LL   Xie Tong T   He Li-Li LL   Tao Jia-Lei JL   Shan Jin-Jun JJ   Wang Shou-Chuan SC  

Metabolomics : Official journal of the Metabolomic Society 20180621 7


<h4>Introduction</h4>Neonatal cholestatic disorders are a group of hepatobiliary diseases occurring in the first 3 months of life. The most common causes of neonatal cholestasis are infantile hepatitis syndrome (IHS) and biliary atresia (BA). The clinical manifestations of the two diseases are too similar to distinguish them. However, early detection is very important in improving the clinical outcome of BA. Currently, a liver biopsy is the only proven and effective method used to differentially  ...[more]

Similar Datasets

2020-08-22 | PXD021051 | JPOST Repository
2014-04-30 | ST000050 | MetabolomicsWorkbench
2022-01-31 | GSE195595 | GEO
2014-09-25 | E-GEOD-53472 | biostudies-arrayexpress
2023-09-06 | GSE228996 | GEO
2014-09-25 | GSE53472 | GEO
2014-09-25 | GSE53471 | GEO
2014-09-25 | E-GEOD-53471 | biostudies-arrayexpress
2011-01-01 | E-GEOD-20983 | biostudies-arrayexpress
2019-03-26 | GSE128821 | GEO